These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15838009)

  • 1. Time for reappraisal of progesterone-receptor testing in breast cancer management.
    MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
    J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
    [No Abstract]   [Full Text] [Related]  

  • 2. Time to stop progesterone receptor testing in breast cancer management.
    Olivotto IA; Truong PT; Speers CH; Bernstein V; Allan SJ; Kelly SJ; Lesperance ML
    J Clin Oncol; 2004 May; 22(9):1769-70. PubMed ID: 15118010
    [No Abstract]   [Full Text] [Related]  

  • 3. It is not time to stop progesterone receptor testing in breast cancer.
    Colomer R; Beltran M; Dorcas J; Cortes-Funes H; Hornedo J; Valentin V; Vargas C; Mendiola C; Ciruelos E
    J Clin Oncol; 2005 Jun; 23(16):3868-9; author reply 3869-70. PubMed ID: 15923595
    [No Abstract]   [Full Text] [Related]  

  • 4. Progesterone receptor testing: not the right time to be buried.
    Colozza M; Larsimont D; Piccart MJ
    J Clin Oncol; 2005 Jun; 23(16):3867-8; author reply 3869-70. PubMed ID: 15923594
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into the role of progesterone receptors in breast cancer.
    Fuqua SA; Cui Y; Lee AV; Osborne CK; Horwitz KB
    J Clin Oncol; 2005 Feb; 23(4):931-2; author reply 932-3. PubMed ID: 15681552
    [No Abstract]   [Full Text] [Related]  

  • 6. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
    Mann GB; Fahey VD; Feleppa F; Buchanan MR
    J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estradiol and progesterone receptors in breast cancer].
    Medina M; Calzada L; Loustaunau E; Torres R; Zárate A
    Arch Invest Med (Mex); 1987; 18(3):235-40. PubMed ID: 3426358
    [No Abstract]   [Full Text] [Related]  

  • 9. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
    Scharl A; Vierbuchen M; Würz H
    Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of therapeutic response in breast carcinoma: predictive factors].
    Nesković-Konstantinović Z
    Srp Arh Celok Lek; 1999; 127(3-4):131-6. PubMed ID: 10500437
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological features of breast cancer in patients under 35].
    Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
    Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen and progesterone receptors in breast cancer].
    Cohen Y; Borovik R
    Harefuah; 1985 Dec; 109(11):350-2. PubMed ID: 3912300
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status].
    Ellinidi VN; Anikeeva NV; Goncharova OA; Krasnozhon DA
    Vopr Onkol; 2005; 51(2):197-9. PubMed ID: 16223000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.